Evaluation of therapeutic effect of IKK epsilon SiRNA on breast cancer cells and development of a peptide-based SiRNA delivery system (hdl:10355/33194)

If you have a University of Missouri login to access this item:
  1. Proceed to the login screen and log in with your University of Missouri Single Sign-On (SSO) credentials.
  2. After signing in you will be redirected to the MOspace home page. Use your browser's back button to return to this page.
  3. Once on the page, refresh/reload the page to access the item.

Proceed to login screen